PRODUCT INFORMATION

 I. TECHNICAL SPECIFICATIONS

Structural / Composition Data

Structure / Formula

 Arg–Gly–Asp motif

Molecular Weight

 ~500–1000 Da (variant dependent)

Appearance

 White – Off White Powder

Purity

 ≥ 95% (HPLC)

Solubility

 Soluble in aqueous buffers

Form(s) Available

 Lyophilized powder / sterile solution

Stability & Shelf Life

Storage

 12 months at 2–8 °C, >24 months at –20 °C

Post-Reconstitution

 6-12 months at 2–8 °C

Stability Notes

 Protect from light

Quality & Compliance

QC Tests

 Pending validation

Intended Use

 As instructions

Documentation

 Available on request

 II. PREPARATION / RECONSTITUTION

General Guidance

 Reconstitute with 1.0 mL sterile water to obtain 100 mg/mL.

Recommendations

 Use within 8–12 hours refrigerated.

 III. MECHANISM & BIOLOGICAL FUNCTION

Mechanism of Action

 Mimics ECM ligands → binds integrins (αvβ3, α5β1) → promotes adhesion, angiogenesis, and targeted cell delivery.

Biological Claims

 - Integrin-mediated targeting
 - Cell adhesion & migration
 - Angiogenesis induction

 IV. APPLICATIONS

Intended Uses

 Targeted drug delivery systems

 V.PACKAGING & PRESENTATION

Available Sizes / Form

Powder Form

100 mg vials

250 mg vials

500 mg vials

1 g vials

Solution Form

1 mL (10% w/v)

5 mL (10% w/v)

10 mL (10% w/v)

20 mL (10% w/v)